Lista de obras -

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2013

A perivascular niche for brain tumor stem cells

artículo científico publicado en 2007

An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

artículo científico publicado en 2011

Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study

artículo científico publicado en 2015

Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer

scientific article published on 30 July 2020

Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study

scientific article published on 09 August 2018

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

artículo científico publicado en 2016

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

artículo científico publicado en 2005

C11ORF95-RELA FUSIONS DRIVE ONCOGENIC NF-KB SIGNALING IN EPENDYMOMA.

artículo científico publicado en 2014

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma

artículo científico publicado en 2014

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

artículo científico publicado en 2014

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

artículo científico publicado en 2009

Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes

artículo científico publicado en 2015

Challenges to curing primary brain tumours

scientific article published on 01 August 2019

Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.

artículo científico publicado en 2012

Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma

artículo científico publicado en 2010

Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma

artículo científico publicado en 2013

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

artículo científico publicado en 2015

Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation

scientific article published on 27 December 2018

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

artículo científico publicado en 2010

Cytogenetic prognostication within medulloblastoma subgroups

artículo científico publicado en 2014

DNA methylation-based classification of central nervous system tumours.

artículo científico publicado en 2018

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

artículo científico publicado en 2014

Diagnostic delay in children with central nervous system tumors and the need to improve education

artículo científico publicado en 2019

Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.

artículo científico publicado en 2012

EMBR-01. MOLECULAR AND CLINICAL HETEROGENEITY IN HISTOLOGICALLY-DIAGNOSED CNS-PNET PATIENTS PROSPECTIVELY TREATED AS A SINGLE ENTITY: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL.

artículo científico publicado en 2018

EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

artículo científico publicado en 2014

Erratum: Corrigendum: C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma

scholarly article published in Nature

Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma

artículo científico publicado en 2014

Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma

artículo científico publicado en 2014

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial

artículo científico publicado en 2018

Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment

artículo científico publicado en 2015

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.

artículo científico publicado en 2016

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

scientific article published on 01 April 2020

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma

artículo científico publicado en 2019

Germline Mutations in Predisposition Genes in Pediatric Cancer

artículo científico publicado en 2015

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

artículo científico publicado en 2013

Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes

artículo científico publicado en 2019

Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment

artículo científico publicado en 2015

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

artículo científico publicado en 2016

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

artículo científico publicado en 2010

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

artículo científico publicado en 2011

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies

artículo científico publicado en 2005

Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma

artículo científico publicado en 2006

LGG-30. EVALUATING PEDIATRIC SPINAL LOW-GRADE GLIOMAS-A 30-YEAR RETROSPECTIVE ANALYSIS.

artículo científico publicado en 2018

Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study

artículo científico publicado en 2016

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY.

artículo científico publicado en 2018

MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas

scientific article published on 23 January 2020

Medulloblastoma

scientific article published on 14 February 2019

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

artículo científico publicado en 2013

Medulloblastoma: Improving cure rates in tandem with reduction in short-term toxicities and long-term treatment-related morbidities

artículo científico publicado en 2020

Molecular characteristics of pediatric high-grade gliomas

artículo científico publicado en 2014

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

artículo científico publicado en 2018

Molecular subgroups of medulloblastoma: the current consensus

artículo científico publicado en 2012

Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study

artículo científico

Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.

artículo científico publicado en 2010

Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome

scientific article published on 30 April 2020

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

artículo científico publicado en 2016

New chemotherapy strategies and biological agents in the treatment of childhood ependymoma

artículo científico publicado en 2009

Novel mutations target distinct subgroups of medulloblastoma.

artículo científico publicado en 2012

Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database

artículo científico publicado en 2009

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

artículo científico publicado en 2021

PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma

artículo científico publicado en 2014

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

artículo científico publicado en 2010

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2011

Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study

artículo científico publicado en 2010

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report

artículo científico publicado en 2007

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study

artículo científico publicado en 2015

Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas

scientific article published on April 2014

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study

artículo científico publicado en 2006

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma

artículo científico publicado en 2010

Proximal dentatothalamocortical tract involvement in posterior fossa syndrome

artículo científico publicado en 2009

QOS-30FUNCTIONAL INDEPENDENCE IN ADULT SURVIVORS OF PEDIATRIC CNS TUMORS: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY.

artículo científico publicado en 2016

Radial glia cells are candidate stem cells of ependymoma

artículo científico publicado en 2005

Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature

artículo científico publicado en 2012

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'

artículo científico publicado en 2019

Resolving medulloblastoma cellular architecture by single-cell genomics

artículo científico publicado en 2019

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus

artículo científico publicado en 2016

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial

scientific article published on 16 May 2018

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

artículo científico publicado en 2005

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

scientific article published on 10 May 2019

Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas

artículo científico publicado en 2012

Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort.

artículo científico publicado en 2018

Spinal changes after craniospinal irradiation in pediatric patients

artículo científico publicado en 2020

Stability of cyclophosphamide in extemporaneous oral suspensions

artículo científico publicado en 2010

Subsequent neoplasms in survivors of childhood central nervous system tumors: risk after modern multimodal therapy

artículo científico publicado en 2014

Subtypes of medulloblastoma have distinct developmental origins

artículo científico publicado en 2010

Survival and late mortality in long-term survivors of pediatric CNS tumors

artículo científico publicado en 2007

Survival and long-term health and cognitive outcomes after low-grade glioma ⬇️

artículo científico publicado el 22 de diciembre de 2010

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

artículo científico publicado en 2016

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

artículo científico publicado en 2014

The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma

artículo científico publicado en 2009

The whole-genome landscape of medulloblastoma subtypes

artículo científico publicado en 2017

Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

artículo científico publicado en 2016

Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007

artículo científico publicado en 2012

Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study

artículo científico publicado en 2015

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

artículo científico publicado en 2015

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

artículo científico publicado en 2013

Working memory abilities among children treated for medulloblastoma: parent report and child performance

artículo científico publicado en 2014

Lista de obras de

A molecular biology and phase II trial of lapatinib in children with refractory CNS malignancies: a pediatric brain tumor consortium study

A perivascular niche for brain tumor stem cells

An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma.

Anterior hypopituitarism in adult survivors of childhood cancers treated with cranial radiotherapy: a report from the St Jude Lifetime Cohort study

Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer

Attainment of Functional and Social Independence in Adult Survivors of Pediatric CNS Tumors: A Report From the St Jude Lifetime Cohort Study

Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes

Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy

C11ORF95-RELA FUSIONS DRIVE ONCOGENIC NF-KB SIGNALING IN EPENDYMOMA.

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma

CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity

Carboplatin-based primary chemotherapy for infants and young children with CNS tumors

Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes

Challenges to curing primary brain tumours

Children's Oncology Group's 2013 blueprint for research: central nervous system tumors.

Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma

Clinico-radiologic characteristics of long-term survivors of diffuse intrinsic pontine glioma

Common variants in ACYP2 influence susceptibility to cisplatin-induced hearing loss

Comprehensive Analysis of Chromatin States in Atypical Teratoid/Rhabdoid Tumor Identifies Diverging Roles for SWI/SNF and Polycomb in Gene Regulation

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

Cytogenetic prognostication within medulloblastoma subgroups

DNA methylation-based classification of central nervous system tumours.

Delayed methotrexate excretion in infants and young children with primary central nervous system tumors and postoperative fluid collections

Diagnostic delay in children with central nervous system tumors and the need to improve education

Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas.

EMBR-01. MOLECULAR AND CLINICAL HETEROGENEITY IN HISTOLOGICALLY-DIAGNOSED CNS-PNET PATIENTS PROSPECTIVELY TREATED AS A SINGLE ENTITY: A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP ACNS0332 TRIAL.

EMBR-15. DIAGNOSTIC RE-EVALUATION AND POOLED CLINICAL DATA ANALYSIS OF PATIENTS WITH PREVIOUS DIAGNOSIS OF CNS-PNET

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

Erratum: Corrigendum: C11orf95–RELA fusions drive oncogenic NF-κB signalling in ependymoma

Evaluation of amifostine for protection against cisplatin-induced serious hearing loss in children treated for average-risk or high-risk medulloblastoma

Examination of risk factors for intellectual and academic outcomes following treatment for pediatric medulloblastoma

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial

Functional MRI in medulloblastoma survivors supports prophylactic reading intervention during tumor treatment

Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

Germline GPR161 Mutations Predispose to Pediatric Medulloblastoma

Germline Mutations in Predisposition Genes in Pediatric Cancer

Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system

Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes

Imaging Patterns and Outcome of Posterior Reversible Encephalopathy Syndrome During Childhood Cancer Treatment

Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome

Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies

Intratumoral hemorrhage among children with newly diagnosed, diffuse brainstem glioma

LGG-30. EVALUATING PEDIATRIC SPINAL LOW-GRADE GLIOMAS-A 30-YEAR RETROSPECTIVE ANALYSIS.

Long-Term Neurocognitive Functioning and Social Attainment in Adult Survivors of Pediatric CNS Tumors: Results From the St Jude Lifetime Cohort Study

MBCL-44. THE MOLECULAR AND CLINICAL LANDSCAPE OF INFANT MEDULLOBLASTOMA (iMB): RESULTS AND MOLECULAR ANALYSIS FROM A PROSPECTIVE, MULTICENTER PHASE II TRIAL (SJYC07)

MBRS-34. MOLECULAR CHARACTERIZATION OF RECURRENT MEDULLOBLASTOMA REVEALS AN UNEXPECTEDLY HIGH INCIDENCE OF SECONDARY MALIGNANCY.

MRI Patterns of Extrapontine Lesion Extension in Diffuse Intrinsic Pontine Gliomas

Medulloblastoma

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.

Medulloblastoma: Improving cure rates in tandem with reduction in short-term toxicities and long-term treatment-related morbidities

Molecular characteristics of pediatric high-grade gliomas

Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

Molecular subgroups of medulloblastoma: the current consensus

Mortality in children with low-grade glioma or glioneuronal tumors: A single-institution study

Neurocognitive outcome 12 months following cerebellar mutism syndrome in pediatric patients with medulloblastoma.

Neuroimaging Findings in Children with Constitutional Mismatch Repair Deficiency Syndrome

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs

New chemotherapy strategies and biological agents in the treatment of childhood ependymoma

Novel mutations target distinct subgroups of medulloblastoma.

Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the Surveillance, Epidemiology, and End Results database

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

PDCT-05. MOLECULAR DIAGNOSTICS REVEAL 60% HIGHER SURVIVAL FOR MOLECULARLY-VERIFIED VERSUS HISTOPATHOLOGICALLY-DIAGNOSED PEDIATRIC SUPRATENTORIAL CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS AND PINEOBLASTOMAS; A REPORT FROM THE CHILDREN’S ONCOLOGY GROUP

Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma

Phase I study of vandetanib during and after radiotherapy in children with diffuse intrinsic pontine glioma

Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study

Phase I trial of lapatinib in children with refractory CNS malignancies: a Pediatric Brain Tumor Consortium study

Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report

Phase I trial of weekly MK-0752 in children with refractory central nervous system malignancies: a pediatric brain tumor consortium study

Phase II Trial of Erlotinib during and after Radiotherapy in Children with Newly Diagnosed High-Grade Gliomas

Phase II study of oxaliplatin in children with recurrent or refractory medulloblastoma, supratentorial primitive neuroectodermal tumors, and atypical teratoid rhabdoid tumors: a pediatric brain tumor consortium study

Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma

Proximal dentatothalamocortical tract involvement in posterior fossa syndrome

QOS-30FUNCTIONAL INDEPENDENCE IN ADULT SURVIVORS OF PEDIATRIC CNS TUMORS: A REPORT FROM THE ST. JUDE LIFETIME COHORT STUDY.

Radial glia cells are candidate stem cells of ependymoma

Radiation therapy and adjuvant chemotherapy in a patient with a malignant glioneuronal tumor and underlying ataxia telangiectasia: a case report and review of the literature

Reply to 'Assembling the brain trust: the multidisciplinary imperative in neuro-oncology'